TMC Life Sciences Berhad

KLSE:TMCLIFE Stok Raporu

Piyasa değeri: RM 923.2m

TMC Life Sciences Berhad Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

TMC Life Sciences Berhad has been growing earnings at an average annual rate of 21%, while the Healthcare industry saw earnings growing at 24.3% annually. Revenues have been growing at an average rate of 13.9% per year. TMC Life Sciences Berhad's return on equity is 4.6%, and it has net margins of 11.7%.

Anahtar bilgiler

21.0%

Kazanç büyüme oranı

21.0%

EPS büyüme oranı

Healthcare Sektör Büyümesi31.5%
Gelir büyüme oranı13.9%
Özkaynak getirisi4.6%
Net Marj11.7%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

TMC Life Sciences Berhad (KLSE:TMCLIFE) Seems To Use Debt Quite Sensibly

Feb 14
TMC Life Sciences Berhad (KLSE:TMCLIFE) Seems To Use Debt Quite Sensibly

We Think TMC Life Sciences Berhad (KLSE:TMCLIFE) Can Stay On Top Of Its Debt

Sep 29
We Think TMC Life Sciences Berhad (KLSE:TMCLIFE) Can Stay On Top Of Its Debt

Investors Met With Slowing Returns on Capital At TMC Life Sciences Berhad (KLSE:TMCLIFE)

Aug 26
Investors Met With Slowing Returns on Capital At TMC Life Sciences Berhad (KLSE:TMCLIFE)

TMC Life Sciences Berhad (KLSE:TMCLIFE) Shareholders Will Want The ROCE Trajectory To Continue

May 26
TMC Life Sciences Berhad (KLSE:TMCLIFE) Shareholders Will Want The ROCE Trajectory To Continue

TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Feb 09
TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Returns On Capital - An Important Metric For TMC Life Sciences Berhad (KLSE:TMCLIFE)

Jan 13
Returns On Capital - An Important Metric For TMC Life Sciences Berhad (KLSE:TMCLIFE)

Would Shareholders Who Purchased TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Three Years Be Happy With The Share price Today?

Dec 22
Would Shareholders Who Purchased TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Three Years Be Happy With The Share price Today?

Should You Use TMC Life Sciences Berhad's (KLSE:TMCLIFE) Statutory Earnings To Analyse It?

Dec 02
Should You Use TMC Life Sciences Berhad's (KLSE:TMCLIFE) Statutory Earnings To Analyse It?

Gelir ve Gider Dağılımı

TMC Life Sciences Berhad nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

KLSE:TMCLIFE Gelir, gider ve kazançlar (MYR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 243464100
31 Mar 243575300
31 Dec 233535700
30 Sep 233324800
30 Jun 233123900
31 Mar 232984900
31 Dec 222774200
30 Sep 222634400
30 Jun 222444100
31 Mar 222262200
31 Dec 212131800
30 Sep 212031700
30 Jun 212012000
30 Jun 201841600
31 May 201901000
29 Feb 202062200
30 Nov 192002200
31 Aug 191952100
31 May 1918733880
28 Feb 1918030880
30 Nov 1817429880
31 Aug 181692800
31 May 1816528280
28 Feb 1816128460
30 Nov 1715728620
31 Aug 1715226790
31 May 1714621790
28 Feb 1714020770
30 Nov 1613619760
31 Aug 1613118740
29 Feb 1612113690
30 Nov 1511613670
31 Aug 1510710550
31 May 1510310610
28 Feb 15989570
30 Nov 14947540
31 Aug 14918520
31 May 14866510
28 Feb 14825500
30 Nov 13783480

Kaliteli Kazançlar: TMCLIFE has high quality earnings.

Büyüyen Kar Marjı: TMCLIFE's current net profit margins (11.7%) are lower than last year (12.6%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: TMCLIFE's earnings have grown significantly by 21% per year over the past 5 years.

Büyüme Hızlandırma: TMCLIFE's earnings growth over the past year (3.5%) is below its 5-year average (21% per year).

Kazançlar vs. Sektör: TMCLIFE earnings growth over the past year (3.5%) exceeded the Healthcare industry 1.6%.

Özkaynak Getirisi

Yüksek ROE: TMCLIFE's Return on Equity (4.6%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y